Nurix Therapeutics NRIX
NASDAQ NRIX
$25.34 -0.17 (-0.67%)
At close: Oct 23, 2026 · 4:00 PM EDT

Nurix Therapeutics (NRIX) Purchase of Investments (2019 - 2026)

Updated

Nurix Therapeutics' Purchase of Investments - Total came in at $149.44 million for fiscal Q3 2026 (quarter ended Aug 31, 2026), up 45.1% from $103 million a year earlier and up 506.8% from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) Purchase of Investments (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Aug 31, 2026, Nurix Therapeutics reported Purchase of Investments - Total of $604.34 million, up 4.3% year-over-year; for FY2025 (ended Nov 30, 2025), it was $455.69 million, down 35.6% from FY2024.

  • Purchase of Investments - Total carries a five-year compound annual growth rate of 10.6% (FY2020 to FY2025).
  • Going back by fiscal year, Purchase of Investments - Total was $707.95 million in FY2024 (+187.4%), $246.33 million in FY2023 (+2.9%), $239.37 million in FY2022 (-31.3%) and $348.5 million in FY2021 (+26.6%).
  • The five-year range for quarterly Purchase of Investments - Total is $15.25 million (fiscal Q1 2022) to $298.22 million (fiscal Q4 2024).
  • Year-over-year, Purchase of Investments - Total increased in four of the last eight quarters, with growth averaging 40.0%.
  • The fastest year-over-year change in Purchase of Investments - Total over five years came in fiscal Q2 2024 (growth of 270.8%), and the weakest in fiscal Q4 2022 (a decline of 70.3%).
  • Business Quant data shows NRIX's Purchase of Investments - Total at $24.63 million (Q2 2026), $255.93 million (Q1 2026) and $174.34 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 307.00 Mn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 919.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 834.00 Mn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 148.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 46.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 42.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.54 Bn
10 Nurix Therapeutics 2.77 Bn 141.68 Mn - 149.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 149.44 Mn
May 31, 2026 24.63 Mn
Feb 28, 2026 255.93 Mn
Nov 30, 2025 174.34 Mn
Aug 31, 2025 103.00 Mn
May 31, 2025 68.17 Mn
Feb 28, 2025 110.18 Mn
Nov 30, 2024 298.22 Mn
Aug 31, 2024 129.82 Mn
May 31, 2024 225.12 Mn
Feb 29, 2024 54.80 Mn
Nov 30, 2023 88.39 Mn
Aug 31, 2023 74.59 Mn
May 31, 2023 60.71 Mn
Feb 28, 2023 22.64 Mn
Nov 30, 2022 26.91 Mn
Aug 31, 2022 132.42 Mn
May 31, 2022 64.79 Mn
Feb 28, 2022 15.25 Mn
Nov 30, 2021 90.68 Mn
API Access

Nurix Therapeutics Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=NRIX&period=max&api_key=YOUR_API_KEY